In an interview, synthetic biologist Peter Carr explains research on synthetic cells, their potential benefits and hazards, ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results